AI-generated summary
The authors report a randomized trial of 116 children aged 8 to 10 with mild myopia, comparing 650-nm red light, a distant-image screen, both combined, and a control group over one year. Combined therapy was associated with slower axial length growth and less myopia progression than control, and no retinal changes were seen on fundus photographs.
- Participants
- 116
- Who or what was studied
- Children aged 8 to 10 years with spherical equivalent error from -1 to -1.5 diopters
- Wavelengths
- 650 nm
- Limits stated in the abstract
- The abstract does not report a control-group comparison of the combined-therapy findings with statistical detail, and the 79.3% reversal figure is described only as potential reversal.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Objective
To assess the efficacy and safety of 650-nm low-level red light (RL) and distant-image therapy (DIT) for myopia.
Methods
A randomized clinical trial. Children aged 8-10 years with a spherical equivalent error (SER) ranging from -1 to -1.5 diopters (D) were enrolled, and were randomly allocated to the following group: RL, DIT, RL + DIT, and control in a 1:1:1:1 ratio. The primary outcomes were changes in SER and axial length (AL).
Results
One hundred and sixteen children randomized, girls accounted for 45.69% (53/116). The median one-year changes in SER were 0.21D (inter-quartile range, IQR: -0.03D to 0.46D), -0.06D (-0.32D to 0.19D), -0.08D (-0.31D to 0.14D), and -0.30D (-0.51D to -0.09D), respectively, for the RL + DIT, RL, DIT, and the control group. The median one-year changes in AL were 0.04 mm (-0.03 mm to 0.13 mm), 0.05 mm (-0.03 mm to 0.14 mm), 0.30 mm (0.22 mm to 0.37 mm), and 0.42 mm (0.35 mm to 0.49 mm), respectively, for the RL + DIT, RL, DIT, and the control group. Fundus photographs revealed no retinal changes across all groups.
Conclusion
Participants who underwent daily 650-nm low-level red light therapy combined with distant-image screen intervention for 12 months demonstrated a significant deceleration in myopia progression, with 79.3% exhibiting potential for reversal of myopia. No safety concerns were identified through OCT and fundus photography. CLINICAL
Trial Registration
ClinicalTrials.gov, NCT06683287.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Myopia, Randomized controlled trial, Control group, Trial registration, Red light therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.